Table of Contents
1. Executive Summary
2. Market Overview
3. Key Market Trends
4. Key Success Factors
5. Globals Market Demand (in Value US$ Mn) Analysis 2014 to 2018 and Forecast, 2019 to 2029
6. Market Background
7. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Region
- 7.1. North America
- 7.2. Latin America
- 7.3. Europe
- 7.4. Middle East and Africa (MEA)
- 7.5. East Asia
- 7.6. South Asia
- 7.7. Oceania
8. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Drug Type
- 8.1. Macrolide Antibiotics (Azithromycin)
- 8.2. Third-Generation Cephalosporin
- 8.2.1. Cefixime
- 8.2.2. Cefotaxime
- 8.2.3. Ceftizoxime
- 8.2.4. Ceftriaxone
- 8.2.5. Cetriaxone
- 8.3. Tetracycline Antibiotics (Doxycycline)
- 8.4. Fluoroquinolones Antibiotics (Gemifloxacin)
- 8.5. Aminoglycoside (Gentamicin)
- 8.6. Aminocyclitol (Spectinomycin)
9. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Therapy Type
- 9.1. Mono Therapy
- 9.2. Dual Therapy
10. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Route of Administration
- 10.1. Oral
- 10.2. Intra Muscular
11. Globals Market Analysis 2014 to 2018 and Forecast 2019 to 2029, by Distribution Channel
- 11.1. Institutional Sales
- 11.1.1. Hospitals
- 11.1.2. Speciality Clinics
- 11.2. Retail Sales
- 11.2.1. Hospital Pharmacy
- 11.2.2. Retail Pharmacy
- 11.2.3. Mail Order Pharmacy
12. North Americas Market Analysis 2014 to 2018 and Forecast 2018 to 2029
13. Latin Americas Market Analysis 2014 to 2018 and Forecast 2019 to 2029
14. Europes Market Analysis 2014 to 2018 and Forecast 2019 to 2029
15. South Asias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
16. East Asias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
17. Oceanias Market Analysis 2014 to 2018 and Forecast 2019 to 2029
18. Middle East and Africas Market Analysis 2014 to 2018 and Forecast 2019 to 2029
19. Competition Analysis
- 19.1. Bayer AG
- 19.2. GlaxoSmithKline Plc.
- 19.3. Pfizer Inc.
- 19.4. Allergan plc
- 19.5. Novartis AG
- 19.6. Sanofi S.A.
- 19.7. Mylan N.V.
- 19.8. Teva Pharmaceutical Industries Ltd.
- 19.9. Baxter International Inc.
- 19.10. Hoffmann-La Roche Ltd.
- 19.11. Merck & Co.
20. Forecast Assumptions: Relevance and Impact
21. Assumptions and Acronyms Used
22. Research Methodology
List of Tables
Table 01: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Region
Table 02: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 2.1: Global Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 03: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy Type
Table 04: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 05: Global Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 06: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 07: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 7.1: North America Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 08: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 09: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 10: North America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 11: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 12: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 12.1: Latin America Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 13: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 14: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 15: Latin America Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 16: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 17: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 17.1: Europe Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 18: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 19: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 20: Europe Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 21: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 22: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 22.1: South Asia Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 23: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 24: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 25: South Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 26: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 27: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 27.1: East Asia Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 28: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 29: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 30: East Asia Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 31: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 32: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 32.1: Oceania Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 33: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 34: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 35: Oceania Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 36: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Country
Table 37: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 37.1: Oceania Market Volume (Tons and Units) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 38: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 39: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 40: Middle East & Africa Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 41: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 42: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 43: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 44: China Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 45: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 46: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 47: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 48: Japan Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
Table 49: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Drug Type
Table 50: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Therapy
Table 51: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Route of Administration
Table 52: India Market Size (US$ Mn) Analysis 2014 to 2018 and Forecast 2019 to 2029, By Distribution Channel
List of Figures
Figure 01: Globals Market Value Share 2018A, By Drug Type
Figure 02: Globals Market Value Share 2018A, By Therapy
Figure 03: Globals Market Value Share 2018A, By Route of Administration
Figure 04: Globals Market Value Share 2018A, By Distribution Channel
Figure 05: Global Market Value Analysis and Forecast, 2017 to 2029 (US$ Mn)
Figure 06: Global Market Value Opportunity Assessment, 2019 to 2029
Figure 07: Global Revenue Share by Region, 2019E and 2029F
Figure 08: Global Market Attractiveness Analysis, By Region, 2019E
Figure 09: Global Revenue Share (in US$ Mn) by Drug Type, 2019E and 2029F
Figure 10: Global Market Attractiveness Analysis, By Drug Type, 2019E
Figure 11: Global Revenue Share by Therapy Type, 2019E and 2029F
Figure 12: Global Market Attractiveness Analysis, By Therapy Type, 2019E
Figure 13: Global Revenue Share by Route of Administration, 2019E and 2029F
Figure 14: Global Market Attractiveness Analysis, By Route of Administration, 2019E
Figure 15: Global Revenue Share by Distribution Channel, 2019E and 2029F
Figure 16: Global Market Attractiveness Analysis, By Distribution Channel, 2019E
Figure 17: North Americas Market Value Share 2019E, By Drug Type
Figure 18: North Americas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 19: North Americas Market Value Share 2019E, By Therapy
Figure 20: North Americas Market Value Share 2019E, By Route of Administration
Figure 21: North Americas Market Value Share 2019E, By Distribution Channel
Figure 22: North Americas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 23: North Americas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 24: North America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 25: North America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 26: North America Market Attractiveness Analysis, By Country
Figure 27: North America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 28: North America Market Attractiveness Analysis, By Country
Figure 29: North America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 30: North America Market Attractiveness Analysis, By Therapy
Figure 31: North America Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 32: North America Market Attractiveness Analysis, By Route of Administration
Figure 33: North America Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 34: North America Market Attractiveness Analysis, By Distribution Channel
Figure 35: North America Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 36: Latin Americas Market Value Share 2019E, By Drug Type
Figure 37: Latin Americas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 38: Latin Americas Market Value Share 2019E, By Therapy
Figure 39: Latin Americas Market Value Share 2019E, By Route of Administration
Figure 40: Latin Americas Market Value Share 2019E, By Distribution Channel
Figure 41: Latin Americas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 42: Latin Americas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 43: Latin America Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 44: Latin America Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 45: Latin America Market Attractiveness Analysis, By Country
Figure 46: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 47: Latin America Market Attractiveness Analysis, By Drug Type
Figure 48: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 49: Latin America Market Attractiveness Analysis, By Therapy
Figure 50: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 51: Latin America Market Attractiveness Analysis, By Route of Administration
Figure 52: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 53: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 54: Latin America Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 55: Europes Market Value Share 2019E, By Drug Type
Figure 56: Europes Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 57: Europes Market Value Share 2019E, By Therapy
Figure 58: Europes Market Value Share 2019E, By Route of Administration
Figure 59: Europes Market Value Share 2019E, By Distribution Channel
Figure 60: Europes Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 61: Europes Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 62: Europe Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 63: Europe Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 64: Europe Market Attractiveness Analysis, By Country
Figure 65: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 66: Europe Market Attractiveness Analysis, By Drug Type
Figure 67: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 68: Europe Market Attractiveness Analysis, By Therapy
Figure 69: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 70: Europe Market Attractiveness Analysis, By Route of Administration
Figure 71: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 72: Europe Market Attractiveness Analysis, By Distribution Channel
Figure 73: Europe Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 74: South Asias Market Value Share 2019E, By Drug Type
Figure 75: South Asias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 76: South Asias Market Value Share 2019E, By Therapy
Figure 77: South Asias Market Value Share 2019E, By Route of Administration
Figure 78: South Asias Market Value Share 2019E, By Distribution Channel
Figure 79: South Asias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 80: South Asias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 81: South Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 82: South Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 83: South Asia Market Attractiveness Analysis, By Country
Figure 84: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 85: South Asia Market Attractiveness Analysis, By Drug Type
Figure 86: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 87: South Asia Market Attractiveness Analysis, By Therapy
Figure 88: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 89: South Asia Market Attractiveness Analysis, By Route of Administration
Figure 90: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 91: South Asia Market Attractiveness Analysis, By Distribution Channel
Figure 92: South Asia Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 93: East Asias Market Value Share 2019E, By Drug Type
Figure 94: East Asias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 95: East Asias Market Value Share 2019E, By Therapy
Figure 96: East Asias Market Value Share 2019E, By Route of Administration
Figure 97: East Asias Market Value Share 2019E, By Distribution Channel
Figure 98: East Asias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 99: East Asias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 100: East Asia Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 101: East Asia Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 102: East Asia Market Attractiveness Analysis, By Country
Figure 103: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 104: East Asia Market Attractiveness Analysis, By Drug Type
Figure 105: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 106: East Asia Market Attractiveness Analysis, By Therapy
Figure 107: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 108: East Asia Market Attractiveness Analysis, By Route of Administration
Figure 109: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 110: East Asia Market Attractiveness Analysis, By Distribution Channel
Figure 111: East Asia Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 112: Oceanias Market Value Share 2019E, By Drug Type
Figure 113: Oceanias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 114: Oceanias Market Value Share 2019E, By Therapy
Figure 115: Oceanias Market Value Share 2019E, By Route of Administration
Figure 116: Oceanias Market Value Share 2019E, By Distribution Channel
Figure 117: Oceanias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 118: Oceanias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 119: Oceania Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 120: Oceania Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 121: Oceania Market Attractiveness Analysis, By Country
Figure 122: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 123: Oceania Market Attractiveness Analysis, By Drug Type
Figure 124: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 125: Oceania Market Attractiveness Analysis, By Therapy
Figure 126: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 127: Oceania Market Attractiveness Analysis, By Route of Administration
Figure 128: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 129: Oceania Market Attractiveness Analysis, By Distribution Channel
Figure 130: Oceania Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 131: Middle East & Africas Market Value Share 2019E, By Drug Type
Figure 132: Middle East & Africas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 133: Middle East & Africas Market Value Share 2019E, By Therapy
Figure 134: Middle East & Africas Market Value Share 2019E, By Route of Administration
Figure 135: Middle East & Africas Market Value Share 2019E, By Distribution Channel
Figure 136: Middle East & Africas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 137: Middle East & Africas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 138: Middle East & Africa Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 139: Middle East & Africa Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 140: Middle East & Africa Market Attractiveness Analysis, By Country
Figure 141: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 142: Middle East & Africa Market Attractiveness Analysis, By Drug Type
Figure 143: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Drug Type
Figure 144: Middle East & Africa Market Attractiveness Analysis, By Therapy
Figure 145: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 146: Middle East & Africa Market Attractiveness Analysis, By Route of Administration
Figure 147: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 148: Middle East & Africa Market Attractiveness Analysis, By Distribution Channel
Figure 149: Middle East & Africa Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 150: Emerging Countries Market Value Share (2019E)
Figure 151: Emerging Countries Market Value (US$ Mn), By Key Countries, 2014A to 2029E
Figure 152: Chinas Market Value Share 2019E, By Drug Type
Figure 153: Chinas Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 154: Chinas Market Value Share 2019E, By Therapy
Figure 155: Chinas Market Value Share 2019E, By Route of Administration
Figure 156: Chinas Market Value Share 2019E, By Distribution Channel
Figure 157: Chinas Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 158: Chinas Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 159: China Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 160: China Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 161: China Market Attractiveness Analysis, By Country
Figure 162: China Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 163: China Market Attractiveness Analysis, By Therapy
Figure 164: China Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 165: China Market Attractiveness Analysis, By Route of Administration
Figure 166: China Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 167: China Market Attractiveness Analysis, By Distribution Channel
Figure 168: China Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 169: Japans Market Value Share 2019E, By Drug Type
Figure 170: Japans Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 171: Japans Market Value Share 2019E, By Therapy
Figure 172: Japans Market Value Share 2019E, By Route of Administration
Figure 173: Japans Market Value Share 2019E, By Distribution Channel
Figure 174: Japans Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 175: Japans Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 176: Japan Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 177: Japan Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 178: Japan Market Attractiveness Analysis, By Country
Figure 179: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 180: Japan Market Attractiveness Analysis, By Therapy
Figure 181: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 182: Japan Market Attractiveness Analysis, By Route of Administration
Figure 183: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 184: Japan Market Attractiveness Analysis, By Distribution Channel
Figure 185: Japan Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Figure 186: Indias Market Value Share 2019E, By Drug Type
Figure 187: Indias Market Value Share 2019E, By Drug Type (3rd Generation Cephalosporin)
Figure 188: Indias Market Value Share 2019E, By Therapy
Figure 189: Indias Market Value Share 2019E, By Route of Administration
Figure 190: Indias Market Value Share 2019E, By Distribution Channel
Figure 191: Indias Market Value Share 2019E, By Distribution Channel (Institutional Sales)
Figure 192: Indias Market Value Share 2019E, By Distribution Channel (Retail Sales)
Figure 193: India Market Size (US$ Mn) Analysis, 2014 to 2018
Figure 194: India Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2019 to 2029
Figure 195: India Market Attractiveness Analysis, By Country
Figure 196: India Market Value Share Analysis, By Region, 2018 & 2029, By Country
Figure 197: India Market Attractiveness Analysis, By Therapy
Figure 198: India Market Value Share Analysis, By Region, 2018 & 2029, By Therapy
Figure 199: India Market Attractiveness Analysis, By Route of Administration
Figure 200: India Market Value Share Analysis, By Region, 2018 & 2029, By Route of Administration
Figure 201: India Market Attractiveness Analysis, By Distribution Channel
Figure 202: India Market Value Share Analysis, By Region, 2018 & 2029, By Distribution Channel
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF